Submental fullness (double chin) can be caused by the following factors:
Ageing – fat distribution changes with age, despite a normal body weight. Fat under the chin can grow while other areas, like the cheeks, lose fat.
Genetics – some people inherit a predisposition to accumulate fat underneath their chin, even though their body weight is low or normal.
Weight – weight gain can also cause a double chin.
The team will be able to assist you with a booking at your nearest Skin Institute clinic offering Belkyra®.
At Skin Institute, we accept cash, Eftpos or credit cards. There are also easy ways to spread your payments with QCard or Afterpay.
BELKYRA® injection is a prescription medicine containing 10 mg/mL deoxycholic acid. It is used for the improvement in the appearance of moderate to severe convexity or fullness associated with fat below the jaws in adults. Do not use in people allergic to this medicine, with infection at site of injection, pregnancy, and lactation. Possible side effects include headaches, difficulty swallowing, nausea, skin tightness, hypertension, injection site bruising/pain/swelling/numbness/redness/tingling/hardness/itching /discolouration/formation of small areas of hardness/warmth and injection site nerve injury. BELKYRA® treatment is not funded on the New Zealand Pharmaceutical Schedule. You will need to pay for this medicine. Normal Doctors visit fees apply. BELKYRA® treatment should be administered only by trained medical professionals. Speak to your specialist about your own situation and about the benefits/risks of this procedure in appearance medicine. For further information, the Data Sheet and Consumer Medicines Information can be accessed at www.medsafe.govt.nz or ask your doctor. If you have any side effects or concerns speak to your doctor. Note: Results from BELKYRA® treatment usually last up to 4 years. Allergan New Zealand Limited, Auckland.
